You are here

Article Text

Article menu

other Versions

Download PDFPDF
Editorial commentary
Sunshine and multiple sclerosis
  1. Bruce V Taylor
  1. Correspondence to Professor Bruce V Taylor, Menzies Research Institute Tasmania, Private Bag 23, Hobart, Tasmania 7001, Australia; bruce.taylor{at}utas.edu.au

https://doi.org/10.1136/jnnp-2012-304825

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In 1960, Donald Acheson1 made the seminal observation that the global distribution of multiple sclerosis (MS) may be related to available hours of sunshine; this observation was met with disbelief at the time. However, over the subsequent more than 50 years, it has become clear that he may well be right. The effect of sunlight exposure and subsequent vitamin D production (generated by photolysis of 7-dehydrocholesterol in the skin by ultraviolet radiation (UVR)) on the onset and progression of MS has become a significant research focus particularly over the last 10 years, with large-scale clinical trials of vitamin D intervention now underway in many countries.

    A …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; externally peer reviewed.

    Linked Articles